These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
83 related articles for article (PubMed ID: 9367534)
1. Immunoaffinity method to identify aggregin, a putative ADP-receptor in human blood platelets. Puri RN; Colman RW Arch Biochem Biophys; 1997 Nov; 347(2):263-70. PubMed ID: 9367534 [TBL] [Abstract][Full Text] [Related]
2. Modulation of platelet responses by 2-[3-(bromo-2-oxopropylthio)]adenosine-5'-diphosphate involves its binding to as well as covalent modification of an ADP-receptor, aggregin. Puri RN; Colman RF; Colman RW Arch Biochem Biophys; 1997 Jul; 343(1):140-5. PubMed ID: 9210656 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of ADP-induced platelet responses by covalent modification of aggregin, a putative ADP receptor, by 8-(4-bromo-2,3-dioxobutylthio)ADP. Puri RN; Kumar A; Chen H; Colman RF; Colman RW J Biol Chem; 1995 Oct; 270(41):24482-8. PubMed ID: 7592664 [TBL] [Abstract][Full Text] [Related]
4. A novel method for chemical modification of functional groups other than a carboxyl group in proteins by N-ethyl-5-phenylisooxazolium-3'-sulfonate (Woodward's reagent-K): inhibition of ADP-induced platelet responses involves covalent modification of aggregin, an ADP receptor. Puri RN; Colman RW Anal Biochem; 1996 Sep; 240(2):251-61. PubMed ID: 8811919 [TBL] [Abstract][Full Text] [Related]
5. Platelet activation by 2-(4-bromo-2,3-dioxobutylthio)adenosine 5'-diphosphate is mediated by its binding to a putative ADP receptor, aggregin. Puri RN; Colman RF; Colman RW Eur J Biochem; 1996 Mar; 236(3):862-70. PubMed ID: 8665907 [TBL] [Abstract][Full Text] [Related]
6. Thrombin-induced platelet aggregation involves an indirect proteolytic cleavage of aggregin by calpain. Puri RN; Zhou FX; Bradford H; Hu CJ; Colman RF; Colman RW Arch Biochem Biophys; 1989 Jun; 271(2):346-58. PubMed ID: 2543293 [TBL] [Abstract][Full Text] [Related]
7. Distinction between glycoprotein IIIa and the 100-kDa membrane protein (aggregin) mediating ADP-induced platelet activation. Colman RW; Figures WR; Wu QX; Chung SY; Morinelli TA; Tuszynski GP; Colman RF; Niewiarowski S Arch Biochem Biophys; 1988 Apr; 262(1):298-306. PubMed ID: 3281588 [TBL] [Abstract][Full Text] [Related]
15. P2Y1-receptors in human platelets which are pharmacologically distinct from P2Y(ADP)-receptors. Fagura MS; Dainty IA; McKay GD; Kirk IP; Humphries RG; Robertson MJ; Dougall IG; Leff P Br J Pharmacol; 1998 May; 124(1):157-64. PubMed ID: 9630355 [TBL] [Abstract][Full Text] [Related]
16. Plasmin-induced platelet aggregation is accompanied by cleavage of aggregin and indirectly mediated by calpain. Puri RN; Zhou FX; Colman RF; Colman RW Am J Physiol; 1990 Dec; 259(6 Pt 1):C862-8. PubMed ID: 2148055 [TBL] [Abstract][Full Text] [Related]
17. Abnormal tyrosine phosphorylation linked to a defective interaction between ADP and its receptor on platelets. Lévy-Toledano S; Maclouf J; Rosa JP; Gallet C; Vallès G; Nurden P; Nurden AT Thromb Haemost; 1998 Sep; 80(3):463-8. PubMed ID: 9759628 [TBL] [Abstract][Full Text] [Related]
18. Two mechanisms for inhibition of ADP-induced platelet shape change by 5'-p-fluorosulfonylbenzoyladenosine. Conversion to adenosine, and covalent modification at an ADP binding site distinct from that which inhibits adenylate cyclase. Mills DC; Figures WR; Scearce LM; Stewart GJ; Colman RF; Colman RW J Biol Chem; 1985 Jul; 260(13):8078-83. PubMed ID: 2989276 [TBL] [Abstract][Full Text] [Related]